Stroke Connection Magazine provides a wealth of post-stroke information, hope and encouragement. The magazine is published six times per year and is used as an outreach and education tool for stroke survivors, caregivers and healthcare providers. In addition, the information contained in the magazine reinforces healthcare provider messages about the importance of stroke prevention, early treatment and rehabilitation. Plavix is an antiplatelet agent. Antiplatelet agents are indicated for the reduction of recurrent stroke and heart attacks in patients with atherosclerosis documented by recent stroke, myocardial infarction or established peripheral arterial disease.
Epidemiological data show that such patients are at increased risk for both stroke and heart attack.
Sanofi and Bristol-Myers Squibb are worldwide health and personal care companies. Sanofi's principal areas of business are pharmaceuticals and diagnostic tests. Earlier this month, Sanofi merged with Synthelabo to form Sanofi-Synthelabo. Bristol-Myers Squibb's principal businesses are ethical pharmaceuticals, consumer products, nutritionals and medical devices. Both Sanofi and Bristol-Myers Squibb are leaders in the research, development and marketing of cardiovascular products worldwide.